Agfa-Gevaert today announced its third quarter results. Including currency effects, Group sales declined 6.0 percent to 741 million Euro. Excluding currency effects, the decline was limited to 1.7 percent.

Agfa-Gevaert announced that Igepa Belux (Belgium) will distribute SYNAPS®, Agfa’s high-quality synthetic paper, in the Belgian and Luxemburg markets.

ORBIS™ Clinical Information System to be deployed progressively at AP-HP’s 37 hospitals